Chronic myelomonocytic leukemia (CMML) is a rare blood cancer of older adults (3 in every 1,000,000 persons) [1, 2] characterized by an increase in clonal CD14+ CD16– classical monocytes and their precursors in the blood and bone marrow [3, 4]. Here, CD14 is linked to chronic myelomonocytic leukemia.